The largest database of trusted experimental protocols

7 protocols using mhc 2 efluor450

1

Immune Profiling of Tumor-Bearing Mice After MVA-TWIST/TRICOM Vaccination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of B7-1, ICAM-1, and LFA-3 was determined by flow cytometry. Treated MC38 cells were stained with FITC-labeled antibodies to CD80 (B7-1), CD54 (ICAM-1) and CD48 (LFA-3) (BD Biosciences, San Jose, CA). Cells were incubated with antibodies for 30 min at 4°C. Samples were acquired on a FACScan flow cytometer (Becton Dickinson, Franklin Lakes, NJ). The effect of MVA-TWIST/TRICOM on splenic immune cell populations was examined in tumor bearing and non-tumor bearing BALB/c mice 17 days after receiving two vaccinations with MVA-TWIST/TRICOM or being left untreated (n = 5/group). Vaccination of tumor bearing mice began 4 days post-implantation of 5 × 104 4T1 mammary tumor cells. Spleens were prepared and stained as described previously [60 (link)], using the following antibodies: CD3e-V500, t-APC, CD8a-Pacific Blue, CD25-FITC, CD44- PerCP-Cy5.5 CD11b-V500, Gr-1-APC, CD11c-PerCP-Cy5.5, CD40-FITC (BD Biosciences); CD62L-PE-Cy7, FoxP3-PE, MHC II-efluor450 (eBioscience, San Diego, CA); and CD49b-PE-Cy7 (Biolegend, San Diego, CA). Tetramer staining (Beckman Coulter, Pasadena, CA) was performed on splenocytes from non-tumor bearing mice following 7 days of in vitro stimulation with 1.0 μg/mL Twist peptide (BALB/c - LYQVLQSDEL). All samples were acquired on a BD Verse flow cytometer. All marker expression was determined using FlowJo software (TreeStar, Inc., Ashland, OR).
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were kept at 4°C while staining in PBS with 0.5% BSA and 2 mM EDTA in the presence of CD16/32 block (BD clone 2.4G2).
The following antibodies were purchased from BD: CD45.1 BV711 (A20), CD117 BUV395 (2B8), CD135 APC & PE-CF594 (A2F10.1), MHC II V500, BV421, BV510 (M5/114.15.2), CD24 BUV496 (M1/69), CD127 BV421 (SB/199), CD45RA PE (14.8), CD19 BV42 1(1D3). From eBioscience: CD117 PE-Cy7 (2B8), CD317 eFluor450 & APC (eBio927), CD115 PE (AFS98), APC eFluor780 anti-CD11c (N418), MHC II eFluor450 (M5/114/15/2), CD24 PE-Cy7 (M1/69), CD172a APC & PerCP-eFluor710 (P84), Siglec-H PerCP-eFluor710 (eBio440C), eFluor450 Ter119 (Ter119), CD105 eFluor450 (MJ7/18), Irf8 PerCP-eFluor710 (V3GYWCH), CD45R eFluor450 (RA3-6B2), NK1.1 eFluor450 (PK136), CD3 eFluor450 (17A2), Irf4 PE (3E4). From Tonbo Biosciences: CD45.1 PE-Cy7 (A20), CD115 PE (AFS98), CD11c APC-Cy7 (N418). From BioLegend: CD115 BV711 (ASF98), CD45.1 Alexa Fluor 488 (A20), Flag (DYKDDDDK) APC (L5).
Lineage cell depletion kit was purchased from Miltenyi. Cells were analyzed on FACSCanto II or FACSAria Fusion flow cytometers (BD), and data analyzed with FlowJo software (Tree Star).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were stained with combinations of following monoclonal fluorescently conjugated antibodies: TCRβ eFluor® 450 (H57-597, eBioscience, San Diego, CA, USA), CD4 FITC (GK1.5, eBioscience), CD8a PerCP-Cyanine5.5 (53–6.7, eBioscience), CD25 APC (PC61.5, eBioscience), FoxP3 PE (NRRF-30, eBioscience), CD45R/B220 APC-Cyanine7 (RA3-6B2, Biolegend, San Diego, CA, USA), IgD Brilliant violet 650™ (11-26c.2a, Biolegend), CD11b Alexa Fluor® 700 (M1/70, Biolegend), F4/80 PE (BM8, Biolegend), PD-1 PE-eFluor™ 610 (J43, eBioscience), CTLA-4 PerCP-Cyanine5.5 (UC10-4B9, Biolegend), IL-10 PerCP-Cyanine5.5 (JES5-16E3, Biolegend), LAP PerCP-Cyanine5.5 (TWT-16B4, Biolegend), CD14 FITC (Sa2-8, eBioscience), CD206 APC (MR6F3, eBioscience), MHC-II e Fluor® 450 (M5/114.15.2, eBioscience). To stain for intracellular murine antigens, cells were first stained for surface antigens, then fixed and permeabilized with intracellular fixation and permeabilization buffer kit (eBioscience) according to the manufacturer’s recommendation. For intracellular IL-10 staining, cells were incubated with PMA (50 ng/ml) and ionomycin (1000 ng/ml) for 2 h, then incubated with Brefeldin A (10.6 μM) and Monensin (2 μM) for 3 h. Data were acquired using BD Fortessa X20 (BD Bioscences, San Diego, CA, USA) and analyzed with FlowJo 7.6 software.
+ Open protocol
+ Expand
4

Immune Cell Profiling in Bronchoalveolar Lavage

Check if the same lab product or an alternative is used in the 5 most similar protocols
The immune cell composition of bronchoalveolar lavages (BAL) was determined by analysing surface expression of MHC-II, CD3e, SiglecF, CD4, CD8, CD11b and CD11c. Briefly, high-affinity Fc receptors (FcRs) were blocked by incubation with purified anti-mouse CD16/CD32 (Fc Block, BD Pharmingen, 553142) for 30 min at 4 °C. Subsequently, the cells were stained with MHC-II-eFluor450 (eBioscience, 48-5321-82, 1/500), CD3e-AlexaFluor488 (BD Pharmingen, 557666, 1/300), SiglecF-PE (BD Pharmingen, 562068, 1/200), CD4-PerCP (BD Pharmingen, 553052, 1/300), CD8-PE-Cy7 (eBioscience, 25-0081-81, 1/300), CD11b-APC-Cy7 (BD Pharmingen, 557657, 1/500) and CD11c-APC (BD Pharmingen, 550261, 1/200) for 1 h at 4 °C. After staining, samples were measured on an LSR II flow cytometer (BD Biosciences, San Jose, CA, USA), and analysed using FlowJo X (TreeStar) software.
+ Open protocol
+ Expand
5

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were kept at 4°C while staining in PBS with 0.5% BSA and 2 mM EDTA in the presence of CD16/32 block (BD clone 2.4G2).
The following antibodies were purchased from BD: CD45.1 BV711 (A20), CD117 BUV395 (2B8), CD135 APC & PE-CF594 (A2F10.1), MHC II V500, BV421, BV510 (M5/114.15.2), CD24 BUV496 (M1/69), CD127 BV421 (SB/199), CD45RA PE (14.8), CD19 BV42 1(1D3). From eBioscience: CD117 PE-Cy7 (2B8), CD317 eFluor450 & APC (eBio927), CD115 PE (AFS98), APC eFluor780 anti-CD11c (N418), MHC II eFluor450 (M5/114/15/2), CD24 PE-Cy7 (M1/69), CD172a APC & PerCP-eFluor710 (P84), Siglec-H PerCP-eFluor710 (eBio440C), eFluor450 Ter119 (Ter119), CD105 eFluor450 (MJ7/18), Irf8 PerCP-eFluor710 (V3GYWCH), CD45R eFluor450 (RA3-6B2), NK1.1 eFluor450 (PK136), CD3 eFluor450 (17A2), Irf4 PE (3E4). From Tonbo Biosciences: CD45.1 PE-Cy7 (A20), CD115 PE (AFS98), CD11c APC-Cy7 (N418). From BioLegend: CD115 BV711 (ASF98), CD45.1 Alexa Fluor 488 (A20), Flag (DYKDDDDK) APC (L5).
Lineage cell depletion kit was purchased from Miltenyi. Cells were analyzed on FACSCanto II or FACSAria Fusion flow cytometers (BD), and data analyzed with FlowJo software (Tree Star).
+ Open protocol
+ Expand
6

Multicolor Flow Cytometry Analysis of Lung Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions from the collagenase lung digest were filtered twice through a 70 µm filter, and cells were harvested by centrifugation and counted. One million cells per sample were aliquoted into 96 well plates and blocked with FC Block (BD Pharmingen: 553142) prior to incubation with a fluorescently-labeled lymphocyte panel of antibodies(CD3,PE, BD Pharmingen: 553064; CD4, APC, BD Pharmingen: 553051; and CD8, FITC, BD Pharmingen: 553031) or macrophage/neutrophil panel (MHCII, eFluor 450, eBiosciences: 48-5321-82; Ly6G, PE, eBiosciences: 12-6931-82; CD11b, PE-Cy7, eBiosciences: 25-0114-82; CD11c, PerCP-Cy5.5, BD Pharmingen: 550993; and F4/80, APC, eBiosciences: 17-4801-82). Fixed cells were then subjected to FACs analysis on a BD LSRII flow cytometer. Populations were determined using FlowJo (Ashland, OR) software as described(20 (link)).
+ Open protocol
+ Expand
7

Pulmonary DC Subsets Analysis in Sema3e-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pulmonary conventional DC subsets were analyzed by FACS from Sema3e-/- or WT mice 3 days after intranasal exposure with a single high dose of HDM [3 (link)]. Briefly, lungs were removed from mice and enzymatically digested using 1 mg/ml collagenase IV (Worthington Biochemical Corporation, Lakewood, NJ) and 0.5 mg/ml DNase from bovine pancreas in RPMI 1640 medium. After Fc blocking, DCs were stained by anti-mouse CD11c-APC (Clone: N418, eBioscience), MHCII eFluor® 450 (Clone: M5/114.15.2, eBioscience), CD11b-PE-Cy7 (Clone: M1/70, BioLegend), and CD103-PerCP-Cy5.5 (Clone: 2E7, BioLegend). Anti-mouse PD-L2-PE (Clone: TY25, BioLegend) and IRF-4 (Clone: IRF4.3E4, BioLegend) antibodies were separately added to the tubes followed by acquisition of the samples using a BD FACS Canto-II (BD, San Diego, CA) and analyzed using FlowJo V10.7.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!